Showing results (2851-2860 of 4,621) with videos related to

Sort By:
Pageof 463
Chemmedchem|July 22, 2014
The mitochondrial amidoxime reducing component (mARC): involvement in metabolic reduction of N-oxides, oximes and N-hydroxyamidinohydrazonesHeyka H Jakobs, Danilo Froriep, Antje Havemeyer, et al.
Chemmedchem|July 23, 2014
Structural and biochemical studies of actin in complex with synthetic macrolide tail analoguesJose H Pereira, Chutima Petchprayoon, Alexander C Hoepker, et al.
Chemmedchem|July 23, 2014
Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1)Yi-Lin Zhang, Ke-Wu Yang, Ya-Jun Zhou, et al.
Chemmedchem|August 1, 2014
Double GC:GC mismatch in dsDNA enhances local dynamics retaining the DNA footprint: a high-resolution NMR studyAnirban Ghosh, Rajiv Kumar Kar, Janarthanan Krishnamoorthy, et al.
Chemmedchem|May 9, 2013
Adamantyl arotinoids that inhibit IκB kinase α and IκB kinase βPaula Lorenzo, María A Ortiz, Rosana Alvarez, et al.
Chemmedchem|May 15, 2013
Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitorsLinrong Zhu, Yuanyuan Li, Ling Qiu, et al.
Chemmedchem|April 10, 2013
Rhenium complexes with visible-light-induced anticancer activityAnja Kastl, Sandra Dieckmann, Kathrin Wähler, et al.
Chemmedchem|April 26, 2013
Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1Ramesh Ekambaram, Erki Enkvist, Angela Vaasa, et al.
Chemmedchem|April 17, 2013
Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonistMichel A Steiner, John Gatfield, Catherine Brisbare-Roch, et al.
Chemmedchem|May 4, 2013
Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligandsAndrew J Thompson, Mark H P Verheij, Jacqueline E van Muijlwijk-Koezen, et al.
Pageof 463